Epivax
An AI/ML Scientist at EpiVax works on analyzing biological datasets and developing models to advance understanding of the adaptive immune system. The role involves designing generative AI frameworks for protein and peptide sequence analysis and collaborating with scientific and technical teams.
Headquarters
Providence, Rhode Island, United States
Company Size
11-50 employees
Founded
1998
EpiVax is an immunoinformatics company that specializes in immunogenicity assessment and sequence optimization for biologic therapeutics and vaccines. Using proprietary computational algorithms and immunology expertise, they predict T‑cell epitopes, identify immunogenic hotspots, and guide sequence engineering to minimize unwanted immune responses or design effective immunogens. EpiVax partners with biopharma and academic teams to support preclinical and clinical programs, combining in silico analyses with experimental validation and regulatory‑oriented reporting.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Epivax.
Epivax didn’t post a salary, so this is our estimate from similar listings.
Postdoctoral Fellow
Merck & Co., Inc.
Postdoctoral Fellow
MSD
Protein Bioinformatics - Postdoctoral Researcher
LLNL
Principal ML Scientist II - Biotherapeutics and Genetic Medicine
AbbVie
PhD scholarship in Computational Immunology and Machine Learning - DTU Health Tech
Oracle
Senior / Principal ML Scientist, Foundation Models for Life Sciences
Lila Sciences